By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kuros Biosciences (Formally known as Cytos Biotech; Merged with Kuros Biosurgery) 

Wagistrasse 25

Postfach  Zurich-Schlieren  8952  Switzerland
Phone: 41-1-733-47-47 Fax: 41-1-733-47-40



Company News
Kuros Biosciences Appoints Chief Medical Officer 3/8/2016 9:37:02 AM
LSP’s Portfolio Company Kuros Biosciences Closes Merger With Cytos And Is Now Listed As Kuros Biosciences Ltd On Swiss Stock Exchange 1/20/2016 9:49:53 AM
Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which Is Renamed Kuros Biosciences 1/20/2016 6:19:48 AM
Cytos Biotechnology Ltd. Will Be Renamed Kuros Biosciences , Constitutes Its Board Of Directors And Appoints Executive Officers 1/8/2016 11:10:16 AM
VC-Backed Kuros Biosurgery Merges with Cytos Biotech 12/3/2015 6:18:33 AM
Cytos Biotechnology AG's Asthma Drug CYT003 Flunks Pivotal Phase 2b Study 4/14/2014 7:19:17 AM
Cytos Biotechnology AG Rights Offering Oversubscribed - CHF 24.3 Million Raised 11/18/2013 6:58:30 AM
Cytos Biotechnology AG to Host Investor and Analyst R&D Day in New York City 10/17/2013 11:53:03 AM
Cytos Biotechnology AG Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma 9/9/2013 8:42:02 AM
Cytos Biotechnology AG Reports Second Quarter 2013 Financial Results and Recent Developments 8/6/2013 6:47:16 AM